Author(s): Field JK, Hansell DM, Duffy SW, Baldwin DR
Abstract Share this page
Abstract Implementation of lung cancer CT screening is currently the subject of a major policy decision within the USA. Findings of the US National Lung Screening Trial showed a 20\% reduction in lung cancer mortality and a 6·7\% decrease in all-cause mortality; subsequently, five US professional and clinical organisations and the US Preventive Services Task Force recommended that screening should be implemented. Should national health services in Europe follow suit? The European community awaits mortality and cost-effectiveness data from the NELSON trial in 2015-16 and pooled findings of European trials. In the intervening years, a recommendation is proposed that a demonstration trial is done in the UK. In this Review, we summarise the existing evidence and identify questions that remain to be answered before the implementation of international lung cancer screening programmes. Copyright © 2013 Elsevier Ltd. All rights reserved.
This article was published in Lancet Oncol
and referenced in Journal of Lung Diseases & Treatment